Here are three points:
1. The shares were sold at $57.92 per share for a total value of $836,773.
2. The 52-week high of NuVasive is $60.09 and the 52-week low is $36.81.
3. The company has a market cap of $2.8 billion.
More articles on devices:
Stryker leads $84M hip & knee orthopedic surgical robot device markets: 5 key points
Disc replacement driving spine industry — KICVentures comments on industry shift: 7 insights
In light of acquisition, Zimmer Biomet joins LDR in push for Mobi-C reimbursement: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
